[ATRA] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
01-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 1.84%
YoY- 17.00%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 28,640 27,357 4,252 2,138 957 1,226 221 2468.47%
PBT -19,049 -31,728 -60,439 -69,816 -71,107 -74,749 -74,570 -59.77%
Tax 0 24 11 -19 1 22 2 -
NP -19,049 -317,520 -604,500 -697,970 -711,080 -747,710 -745,720 -91.34%
Tax Rate - - - - - - - -
Total Cost 47,689 344,877 608,752 700,108 712,037 748,936 745,941 -84.03%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -66.51 -1,160.65 -14,216.84 -32,645.93 -74,303.03 -60,987.77 -337,429.86 -99.66%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -3.10 -5.65 -13.98 -16.40 -16.91 -17.98 -18.07 -69.15%
EPS Diluted -3.10 -5.65 -13.98 -16.40 -16.91 -17.98 -18.07 -69.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.